American Vanguard (AVD) Projected to Release Earnings on Thursday

American Vanguard (NYSE:AVD) is expected to post its Q2 2026 results before the market opens on Thursday, July 30th. Analysts expect American Vanguard to post earnings of $0.09 per share and revenue of $135.00 million for the quarter. Parties can find conference call details on the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Thursday, July 30, 2026 at 5:00 PM ET.

American Vanguard (NYSE:AVD) last released its earnings results on Wednesday, May 6th. The basic materials company reported ($0.14) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.08). The business had revenue of $123.57 million during the quarter, compared to the consensus estimate of $120.00 million. American Vanguard had a negative net margin of 8.71% and a negative return on equity of 4.13%.

American Vanguard Stock Up 3.0%

Shares of NYSE AVD opened at $2.60 on Thursday. The company has a market cap of $74.53 million, a price-to-earnings ratio of -1.64 and a beta of 1.41. The company has a current ratio of 2.32, a quick ratio of 1.41 and a debt-to-equity ratio of 1.39. American Vanguard has a 12 month low of $2.05 and a 12 month high of $5.92. The stock has a 50-day moving average price of $2.72 and a two-hundred day moving average price of $3.41.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered shares of American Vanguard from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, May 18th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, American Vanguard currently has an average rating of “Sell”.

Insider Buying and Selling

In related news, Director Patrick E. Gottschalk purchased 25,000 shares of American Vanguard stock in a transaction on Tuesday, May 19th. The shares were purchased at an average price of $2.70 per share, for a total transaction of $67,500.00. Following the transaction, the director owned 191,705 shares of the company’s stock, valued at approximately $517,603.50. This represents a 15.00% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 5.60% of the company’s stock.

Institutional Trading of American Vanguard

Institutional investors have recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. raised its holdings in American Vanguard by 1,397.5% during the 4th quarter. Russell Investments Group Ltd. now owns 336,277 shares of the basic materials company’s stock worth $1,285,000 after purchasing an additional 313,821 shares during the last quarter. Curi Capital LLC boosted its stake in shares of American Vanguard by 1,285.5% in the 2nd quarter. Curi Capital LLC now owns 289,573 shares of the basic materials company’s stock valued at $1,135,000 after purchasing an additional 268,673 shares during the last quarter. Federated Hermes Inc. increased its position in shares of American Vanguard by 371.1% during the second quarter. Federated Hermes Inc. now owns 303,179 shares of the basic materials company’s stock worth $1,188,000 after buying an additional 238,822 shares during the period. AQR Capital Management LLC increased its position in shares of American Vanguard by 117.8% during the first quarter. AQR Capital Management LLC now owns 436,687 shares of the basic materials company’s stock worth $1,921,000 after buying an additional 236,212 shares during the period. Finally, American Century Companies Inc. raised its stake in American Vanguard by 59.7% during the second quarter. American Century Companies Inc. now owns 248,162 shares of the basic materials company’s stock worth $973,000 after buying an additional 92,807 shares during the last quarter. 79.00% of the stock is currently owned by institutional investors.

American Vanguard Company Profile

American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.

The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.